Arcutis Biotherapeutics (ARQT) Work In Process (2022 - 2026)

Arcutis Biotherapeutics' Work In Process history runs 5 years deep, the most recent figure standing at $6.3 million for Q1 2026.

• In Q1 2026, Work In Process rose 708.56% year-over-year to $6.3 million; the TTM figure through Mar 2026 stood at $6.3 million (up 708.56% YoY), while the FY2025 annual figure was $5.0 million, up 761.82% from the prior year.
• Work In Process for Q1 2026 stood at $6.3 million, up from $5.0 million in the prior quarter.
• The five-year high for Work In Process was $6.3 million in Q1 2026, with the low at $116000.0 in Q3 2022.
• The 5-year median for Work In Process is $783000.0 (2025), against an average of $1.8 million.
• The sharpest annual moves came in 2024 and 2025: Work In Process soared 1158.47% in 2024, then slumped 66.0% in 2025.
• Arcutis Biotherapeutics' Work In Process stood at $395000.0 in 2022, then increased by 23.04% to $486000.0 in 2023, then grew by 20.16% to $584000.0 in 2024, then jumped by 761.82% to $5.0 million in 2025, then increased by 25.79% to $6.3 million in 2026.
• Business Quant data shows ARQT's Work In Process at $6.3 million in Q1 2026, $5.0 million in Q4 2025, and $4.7 million in Q3 2025.